CymaBay Therapeutics, Inc.

AMERIPRISE FINANCIAL INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

25,711

Value ($000)

607

Weight

0.0%

2020 Q2 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	607	0.0%	25,711	12/31/2023
2022 Q4	2/14/2023	73	0.0%	11,561	12/31/2022
2022 Q3	11/14/2022	65	0.0%	18,511	9/30/2022
2022 Q2	8/15/2022	66	0.0%	22,261	6/30/2022
2022 Q1	5/16/2022	74	0.0%	23,661	3/31/2022
2021 Q4	2/14/2022	79	0.0%	23,511	12/31/2021
2021 Q3	11/15/2021	120	0.0%	32,645	9/30/2021
2021 Q2	8/16/2021	149	0.0%	34,350	6/30/2021
2021 Q1	5/17/2021	161	0.0%	35,625	3/31/2021
2020 Q4	2/12/2021	243	0.0%	43,801	12/31/2020
2020 Q3	11/16/2020	229	0.0%	31,696	9/30/2020
2020 Q2	8/14/2020	60	0.0%	17,021	6/30/2020